Global Methylene Blue Enteric-coated Sustained-release Tablets Market Growth 2026-2032

July 2026 | 84 pages | ID: GE9137BE885EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Methylene Blue Enteric-coated Sustained-release Tablets market size is predicted to grow from US$ 15.46 million in 2025 to US$ 39.12 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.

Methylene Blue Enteric-coated Sustained-release Tablets are solid enteric-coated and sustained-release preparations with methylene blue as the main active ingredient. Adopting combined technologies of enteric coating and sustained-release formulation, the drug avoids decomposition and destruction in the stomach, enabling the active ingredients to be released slowly and continuously in a targeted manner in the intestinal tract. With a unique targeted staining effect, it is mainly applied in colonoscopy examinations to improve the identification of intestinal mucosal lesions and assist the early screening and diagnosis of tiny colorectal lesions. The sustained-release dosage form steadily controls the drug release rate, reduces local irritation, and improves medication safety and tolerability, providing important auxiliary medication support for the accurate clinical diagnosis and treatment of intestinal diseases.In 2025, global production of Methylene Blue Enteric-coated Sustained-release Tablets reached approximately 2.1 million bottles.

Methylene Blue Enteric-coated Sustained-release Tablets, as the world?s first oral colon-targeted staining diagnostic preparation, has become a key product in the field of early colorectal cancer screening by virtue of its unique enteric-coated and sustained-release technology and prominent clinical value. Originally developed by Cosmo Pharma, it was first launched in the European Union and later introduced and approved in China by C&P Pharmaceutical, filling the domestic gap in oral diagnostic drugs for intestinal staining. With the rising global incidence of colorectal cancer and growing awareness of early screening, the demand for colonoscopy continues to expand, creating broad market prospects for this product. Compared with traditional intraoperative staining methods, this drug features convenient oral administration and can be taken simultaneously during intestinal preparation, greatly improving examination efficiency and patient compliance. Its clinical advantages lie in precisely staining the intestinal mucosa, elevating the detection rate of minute and flat lesions, facilitating early clinical intervention and optimizing patient prognosis. At present, the market competition pattern remains favorable. Supported by patented technologies and first-mover advantages, the product has formed high market barriers. With the continuous promotion of clinical indications and the expected inclusion in medical insurance, its market penetration is projected to increase steadily in the future, making it a vital growth driver in the field of intestinal disease diagnosis.

LP Information, Inc. (LPI) ' newest research report, the ?Methylene Blue Enteric-coated Sustained-release Tablets Industry Forecast? looks at past sales and reviews total world Methylene Blue Enteric-coated Sustained-release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Methylene Blue Enteric-coated Sustained-release Tablets sales for 2026 through 2032. With Methylene Blue Enteric-coated Sustained-release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Methylene Blue Enteric-coated Sustained-release Tablets industry.

This Insight Report provides a comprehensive analysis of the global Methylene Blue Enteric-coated Sustained-release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Methylene Blue Enteric-coated Sustained-release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Methylene Blue Enteric-coated Sustained-release Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Methylene Blue Enteric-coated Sustained-release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Methylene Blue Enteric-coated Sustained-release Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Methylene Blue Enteric-coated Sustained-release Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 25 mg
  • 50 mg
Segmentation by Dosage Form:
  • Enteric-coated Sustained-release Tablets
  • Colon-targeted Sustained-release Solid Preparation
Segmentation by Sales Channel:
  • Hospital
  • Retail
  • Online
Segmentation by Application:
  • Colorectal Lesion Screening
  • Intestinal Mucosa Staining Imaging
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Cosmo Pharmaceuticals NV
Key Questions Addressed in this Report
What is the 10-year outlook for the global Methylene Blue Enteric-coated Sustained-release Tablets market?
What factors are driving Methylene Blue Enteric-coated Sustained-release Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Methylene Blue Enteric-coated Sustained-release Tablets market opportunities vary by end market size?
How does Methylene Blue Enteric-coated Sustained-release Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Methylene Blue Enteric-coated Sustained-release Tablets by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Methylene Blue Enteric-coated Sustained-release Tablets by Country/Region, 2021, 2025 & 2032
2.2 Methylene Blue Enteric-coated Sustained-release Tablets Segment by Type
  2.2.1 25 mg
  2.2.2 50 mg
  2.2.3 Methylene Blue Enteric-coated Sustained-release Tablets Sales by Type
    2.2.3.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Sale Price by Type (2021-2026)
2.3 Methylene Blue Enteric-coated Sustained-release Tablets Segment by Dosage Form
  2.3.1 Enteric-coated Sustained-release Tablets
  2.3.2 Colon-targeted Sustained-release Solid Preparation
  2.3.3 Methylene Blue Enteric-coated Sustained-release Tablets Sales by Dosage Form
    2.3.3.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Sales Market Share by Dosage Form (2021-2026)
    2.3.3.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Revenue and Market Share by Dosage Form (2021-2026)
    2.3.3.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Sale Price by Dosage Form (2021-2026)
2.4 Methylene Blue Enteric-coated Sustained-release Tablets Segment by Sales Channel
  2.4.1 Hospital
  2.4.2 Retail
  2.4.3 Online
  2.4.4 Methylene Blue Enteric-coated Sustained-release Tablets Sales by Sales Channel
    2.4.4.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Sales Market Share by Sales Channel (2021-2026)
    2.4.4.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Revenue and Market Share by Sales Channel (2021-2026)
    2.4.4.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Sale Price by Sales Channel (2021-2026)
2.5 Methylene Blue Enteric-coated Sustained-release Tablets Segment by Application
  2.5.1 Colorectal Lesion Screening
  2.5.2 Intestinal Mucosa Staining Imaging
  2.5.3 Others
  2.5.4 Methylene Blue Enteric-coated Sustained-release Tablets Sales by Application
    2.5.4.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Sale Market Share by Application (2021-2026)
    2.5.4.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Revenue and Market Share by Application (2021-2026)
    2.5.4.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Breakdown Data by Company
  3.1.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Annual Sales by Company (2021-2026)
  3.1.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Sales Market Share by Company (2021-2026)
3.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Annual Revenue by Company (2021-2026)
  3.2.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Revenue by Company (2021-2026)
  3.2.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Methylene Blue Enteric-coated Sustained-release Tablets Sale Price by Company
3.4 Key Manufacturers Methylene Blue Enteric-coated Sustained-release Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Methylene Blue Enteric-coated Sustained-release Tablets Product Location Distribution
  3.4.2 Players Methylene Blue Enteric-coated Sustained-release Tablets Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR METHYLENE BLUE ENTERIC-COATED SUSTAINED-RELEASE TABLETS BY GEOGRAPHIC REGION

4.1 World Historic Methylene Blue Enteric-coated Sustained-release Tablets Market Size by Geographic Region (2021-2026)
  4.1.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Methylene Blue Enteric-coated Sustained-release Tablets Market Size by Country/Region (2021-2026)
  4.2.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Methylene Blue Enteric-coated Sustained-release Tablets Sales Growth
4.4 APAC Methylene Blue Enteric-coated Sustained-release Tablets Sales Growth
4.5 Europe Methylene Blue Enteric-coated Sustained-release Tablets Sales Growth
4.6 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Sales Growth

5 AMERICAS

5.1 Americas Methylene Blue Enteric-coated Sustained-release Tablets Sales by Country
  5.1.1 Americas Methylene Blue Enteric-coated Sustained-release Tablets Sales by Country (2021-2026)
  5.1.2 Americas Methylene Blue Enteric-coated Sustained-release Tablets Revenue by Country (2021-2026)
5.2 Americas Methylene Blue Enteric-coated Sustained-release Tablets Sales by Type (2021-2026)
5.3 Americas Methylene Blue Enteric-coated Sustained-release Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Methylene Blue Enteric-coated Sustained-release Tablets Sales by Region
  6.1.1 APAC Methylene Blue Enteric-coated Sustained-release Tablets Sales by Region (2021-2026)
  6.1.2 APAC Methylene Blue Enteric-coated Sustained-release Tablets Revenue by Region (2021-2026)
6.2 APAC Methylene Blue Enteric-coated Sustained-release Tablets Sales by Type (2021-2026)
6.3 APAC Methylene Blue Enteric-coated Sustained-release Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Methylene Blue Enteric-coated Sustained-release Tablets by Country
  7.1.1 Europe Methylene Blue Enteric-coated Sustained-release Tablets Sales by Country (2021-2026)
  7.1.2 Europe Methylene Blue Enteric-coated Sustained-release Tablets Revenue by Country (2021-2026)
7.2 Europe Methylene Blue Enteric-coated Sustained-release Tablets Sales by Type (2021-2026)
7.3 Europe Methylene Blue Enteric-coated Sustained-release Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets by Country
  8.1.1 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Methylene Blue Enteric-coated Sustained-release Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Methylene Blue Enteric-coated Sustained-release Tablets
10.3 Manufacturing Process Analysis of Methylene Blue Enteric-coated Sustained-release Tablets
10.4 Industry Chain Structure of Methylene Blue Enteric-coated Sustained-release Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Methylene Blue Enteric-coated Sustained-release Tablets Distributors
11.3 Methylene Blue Enteric-coated Sustained-release Tablets Customer

12 WORLD FORECAST REVIEW FOR METHYLENE BLUE ENTERIC-COATED SUSTAINED-RELEASE TABLETS BY GEOGRAPHIC REGION

12.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Market Size Forecast by Region
  12.1.1 Global Methylene Blue Enteric-coated Sustained-release Tablets Forecast by Region (2027-2032)
  12.1.2 Global Methylene Blue Enteric-coated Sustained-release Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Methylene Blue Enteric-coated Sustained-release Tablets Forecast by Type (2027-2032)
12.7 Global Methylene Blue Enteric-coated Sustained-release Tablets Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Cosmo Pharmaceuticals NV
  13.1.1 Cosmo Pharmaceuticals NV Company Information
  13.1.2 Cosmo Pharmaceuticals NV Methylene Blue Enteric-coated Sustained-release Tablets Product Portfolios and Specifications
  13.1.3 Cosmo Pharmaceuticals NV Methylene Blue Enteric-coated Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Cosmo Pharmaceuticals NV Main Business Overview
  13.1.5 Cosmo Pharmaceuticals NV Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Methylene Blue Enteric-coated Sustained-releaseTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Methylene Blue Enteric-coated Sustained-releaseTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 25 mg
Table 4. Major Players of 50 mg
Table 5. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Type (2021-2026) & (Units)
Table 6. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Type (2021-2026)
Table 7. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Type (2021-2026)
Table 9. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Enteric-coated Sustained-releaseTablets
Table 11. Major Players of Colon-targeted Sustained-release Solid Preparation
Table 12. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Dosage Form (2021-2026) & (Units)
Table 13. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Dosage Form (2021-2026)
Table 14. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Dosage Form (2021-2026) & ($ million)
Table 15. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Dosage Form (2021-2026)
Table 16. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Sales Channel (2021-2026) & (Units)
Table 21. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Sales Channel (2021-2026)
Table 22. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Sales Channel (2021-2026) & ($ million)
Table 23. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Sales Channel (2021-2026)
Table 24. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 25. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sale by Application (2021-2026) & (Units)
Table 26. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sale Market Share by Application (2021-2026)
Table 27. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Application (2021-2026) & ($ million)
Table 28. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Application (2021-2026)
Table 29. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Company (2021-2026) & (Units)
Table 31. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Company (2021-2026)
Table 32. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Company (2021-2026)
Table 34. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Methylene Blue Enteric-coated Sustained-releaseTablets Producing Area Distribution and Sales Area
Table 36. Players Methylene Blue Enteric-coated Sustained-releaseTablets Products Offered
Table 37. Methylene Blue Enteric-coated Sustained-releaseTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share Geographic Region (2021-2026)
Table 42. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Country/Region (2021-2026) & (Units)
Table 45. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Country/Region (2021-2026)
Table 46. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Country (2021-2026) & (Units)
Table 49. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Country (2021-2026)
Table 50. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Type (2021-2026) & (Units)
Table 52. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Application (2021-2026) & (Units)
Table 53. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Region (2021-2026) & (Units)
Table 54. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Region (2021-2026)
Table 55. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Type (2021-2026) & (Units)
Table 57. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Application (2021-2026) & (Units)
Table 58. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Country (2021-2026) & (Units)
Table 59. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Type (2021-2026) & (Units)
Table 61. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of Methylene Blue Enteric-coated Sustained-releaseTablets
Table 67. Key Market Challenges & Risks of Methylene Blue Enteric-coated Sustained-releaseTablets
Table 68. Key Industry Trends of Methylene Blue Enteric-coated Sustained-releaseTablets
Table 69. Methylene Blue Enteric-coated Sustained-releaseTablets Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Methylene Blue Enteric-coated Sustained-releaseTablets Distributors List
Table 72. Methylene Blue Enteric-coated Sustained-releaseTablets Customer List
Table 73. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Cosmo Pharmaceuticals NV Basic Information, Methylene Blue Enteric-coated Sustained-releaseTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Cosmo Pharmaceuticals NV Methylene Blue Enteric-coated Sustained-releaseTablets Product Portfolios and Specifications
Table 89. Cosmo Pharmaceuticals NV Methylene Blue Enteric-coated Sustained-releaseTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Cosmo Pharmaceuticals NV Main Business
Table 91. Cosmo Pharmaceuticals NV Latest Developments

LIST OF FIGURES

Figure 1. Picture of Methylene Blue Enteric-coated Sustained-releaseTablets
Figure 2. Methylene Blue Enteric-coated Sustained-releaseTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Country/Region (2025)
Figure 10. Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 25 mg
Figure 12. Product Picture of 50 mg
Figure 13. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Type in 2026
Figure 14. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Enteric-coated Sustained-releaseTablets
Figure 16. Product Picture of Colon-targeted Sustained-release Solid Preparation
Figure 17. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Dosage Form in 2026
Figure 18. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Dosage Form (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Sales Channel in 2026
Figure 23. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Sales Channel (2021-2026)
Figure 24. Methylene Blue Enteric-coated Sustained-releaseTablets Consumed in Colorectal Lesion Screening
Figure 25. Global Methylene Blue Enteric-coated Sustained-releaseTablets Market: Colorectal Lesion Screening (2021-2026) & (Units)
Figure 26. Methylene Blue Enteric-coated Sustained-releaseTablets Consumed in Intestinal Mucosa Staining Imaging
Figure 27. Global Methylene Blue Enteric-coated Sustained-releaseTablets Market: Intestinal Mucosa Staining Imaging (2021-2026) & (Units)
Figure 28. Methylene Blue Enteric-coated Sustained-releaseTablets Consumed in Others
Figure 29. Global Methylene Blue Enteric-coated Sustained-releaseTablets Market: Others (2021-2026) & (Units)
Figure 30. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sale Market Share by Application (2025)
Figure 31. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Application in 2025
Figure 32. Methylene Blue Enteric-coated Sustained-releaseTablets Sales by Company in 2025 (Units)
Figure 33. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Company in 2025
Figure 34. Methylene Blue Enteric-coated Sustained-releaseTablets Revenue by Company in 2025 ($ millions)
Figure 35. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Company in 2025
Figure 36. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Sales 2021-2026 (Units)
Figure 39. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Revenue 2021-2026 ($ millions)
Figure 40. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Sales 2021-2026 (Units)
Figure 41. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Revenue 2021-2026 ($ millions)
Figure 42. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Sales 2021-2026 (Units)
Figure 43. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Sales 2021-2026 (Units)
Figure 45. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Revenue 2021-2026 ($ millions)
Figure 46. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Country in 2025
Figure 47. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Country (2021-2026)
Figure 48. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Type (2021-2026)
Figure 49. Americas Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Application (2021-2026)
Figure 50. United States Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Region in 2025
Figure 55. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Region (2021-2026)
Figure 56. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Type (2021-2026)
Figure 57. APAC Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Application (2021-2026)
Figure 58. China Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. India Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Country in 2025
Figure 66. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share by Country (2021-2026)
Figure 67. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Type (2021-2026)
Figure 68. Europe Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Application (2021-2026)
Figure 69. Germany Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. France Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share by Application (2021-2026)
Figure 77. Egypt Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Methylene Blue Enteric-coated Sustained-releaseTablets in 2026
Figure 83. Manufacturing Process Analysis of Methylene Blue Enteric-coated Sustained-releaseTablets
Figure 84. Industry Chain Structure of Methylene Blue Enteric-coated Sustained-releaseTablets
Figure 85. Channels of Distribution
Figure 86. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Forecast by Region (2027-2032)
Figure 87. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Methylene Blue Enteric-coated Sustained-releaseTablets Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Methylene Blue Enteric-coated Sustained-releaseTablets Revenue Market Share Forecast by Application (2027-2032)


More Publications